ALTERITY THERAPEUTICS NEW (PRNAD) Stock Price, News & Analysis
Company Description
This page collects what Stock Titan holds for PRNAD, including price data, SEC filings, and short interest trends.
Latest News
SEC Filings
ALTERITY THERAPEUTICS NEW has filed 10 recent SEC filings, including 8 Form 6-K, 2 Form 4. The most recent filing was submitted on July 9, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PRNAD SEC filings →
Short Interest History
Short interest in ALTERITY THERAPEUTICS NEW (PRNAD) currently stands at 10.5 thousand shares, up 525750.0% from the previous reporting period, representing 0.0% of the float. Since June 2026, short interest has increased by 525750.0%.
Days to Cover History
Days to cover for ALTERITY THERAPEUTICS NEW (PRNAD) currently stands at 1000.0 days, up 49899.5% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since June 2026, the figure has increased by 49899.5%. Across the settlements charted above, it has ranged from 2.0 to 1000.0 days.